February 25, 2025 08:00 AM ESTUpdated 10:35 AM
Special

Who’s lead­ing LGBTQ+ in­clu­sion in bio­phar­ma? Nom­i­nate them for End­points’ an­nu­al re­port

Kyle LaHucik

Senior Reporter

For the fourth year run­ning, End­points News will high­light the biotech lead­ers who are paving the way for the LGBTQ+ com­mu­ni­ty. Nom­i­na­tions …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Where the mon­ey is: The top 100 ven­ture in­vestors in biotech

Al­ny­lam eyes big­ger dis­eases in more tis­sue types at ‘in­flec­tion point’ for siR­NA

Eli Lil­ly ex­pands Zep­bound sin­gle-dose vial op­tions at low­er price

Trump blog: HHS says there's no ex­pec­ta­tion to re­ply to 'What did you do last week?' email

Al­con tried to sink Au­ri­on's IPO in 'Valen­tine's Day mas­sacre,' new law­suits say

sponsored

How AI can ad­dress on­go­ing chal­lenges in the life sci­ences in­dus­try

A service from the Financial Times